drugset / Trial / NCT01860196

Efficacy and Safety of Meditoxin® Injection for Cervical Dystonia in Adults With Cerebral Palsy

NCT01860196

Phase 4 Completed 17 enrolled Seoul National University Hospital
RandomizedCrossoverQuadruple-blindTreatment

Summary

This study aimed to compare the efficacy and safety of Meditoxin® injection for cervical dystonia in adults with cerebral palsy. It is a placebo controlled, Cross-over, Double blind, Randomized, Clinical trial.

Timeline

Start
2013-06
Primary completion
2017-03
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic

Indications